Medicines Australia welcomes Morrison government ministry

28 May 2019
medicines-australia-large

Pharma trade group Medicines Australia welcomes the appointment of the Morrison government Ministry following the May 18 federal election, which, unexpectedly, returned the Liberal Party to power and beating the Labor Party that had been expected to win.

With the recent confirmation that Prime Minister Scott Morrison MP will lead a majority government and the “appointment of an experienced Ministry, Medicines Australia looks forward to working with members of the Ministry to provide stability and continuity for the continued investment of the innovative pharmaceutical sector and the research and development capabilities of Australia,” the group said.

Medicines Australia chief executive Elizabeth de Somer said: “In particular, Medicines Australia is delighted to see the continuation of the Hon Greg Hunt MP in the health portfolio as Minister for Health. Prime Minister Morrison has made the right call in keeping the critical portfolio of Health in the capable hands of Minister Hunt, as we continue to implement the improvements agreed under the 2017 Strategic Agreement, streamline processes and reduce delays in access to new and breakthrough medicines.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical